SCHEMBL14101431

SCHEMBL14101431

c1ccc(-c2cccc(-c3ccc4ccc5c(-c6ccc7sc8ccc(-c9ccc%10ccc%11c(-c%12cccc(-c%13ccccc%13)c%12)ccc%12ccc9c%10c%12%11)cc8c7c6)ccc6ccc3c4c65)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 3/20 0.40
F9 P00740 3/20 0.38
LIMK1 P53667 1/20 0.38
MAP3K8 P41279 2/20 0.36
ROCK1 Q13464 1/20 0.36
PIK3CA P42336 1/20 0.35
PI4KA P42356 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
PIM1 P11309 2/20 0.34
S1PR4 O95977 2/20 0.34
S1PR5 Q9H228 2/20 0.34
SLC9A1 P19634 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
ERBB2 P04626 1/20 0.33
CYP1A2 P05177 1/20 0.33
FYN P06241 1/20 0.33
MAOA P21397 1/20 0.33
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101546 0.99 F9 (0.40) PIM3F9LIMK1MAP3K8ROCK1
SCHEMBL14101433 0.99 F9 (0.40) PIM3F9LIMK1MAP3K8ROCK1
SCHEMBL14101537 0.97 PIM3 (0.39) PIM3F9LIMK1MAP3K8ROCK1
SCHEMBL14101538 0.97 PIM3 (0.39) PIM3F9LIMK1MAP3K8ROCK1
SCHEMBL14101670 0.97 F9 (0.40) PIM3F9LIMK1MAP3K8ROCK1
SCHEMBL14101475 0.97 F9 (0.40) PIM3F9LIMK1MAP3K8ROCK1
SCHEMBL14101566 0.97 PIM3 (0.42) PIM3F9LIMK1ROCK1PIK3CA
SCHEMBL14101542 0.96 PIM3 (0.39) PIM3F9LIMK1MAP3K8ROCK1
SCHEMBL14101531 0.96 PIM3 (0.39) PIM3F9LIMK1MAP3K8ROCK1
SCHEMBL14101667 0.95 PIM3 (0.41) PIM3F9LIMK1ROCK1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR PIM3 2288/4885F9 3290/4885LIMK1 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.